annual accounts payable:
$789.50M+$182.90M(+30.15%)Summary
- As of today (June 29, 2025), REGN annual accounts payable is $789.50 million, with the most recent change of +$182.90 million (+30.15%) on December 31, 2024.
- During the last 3 years, REGN annual accounts payable has risen by +$225.50 million (+39.98%).
- REGN annual accounts payable is now at all-time high.
Performance
REGN Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$705.50M-$84.00M(-10.64%)Summary
- As of today (June 29, 2025), REGN quarterly accounts payable is $705.50 million, with the most recent change of -$84.00 million (-10.64%) on March 31, 2025.
- Over the past year, REGN quarterly accounts payable has increased by +$34.20 million (+5.09%).
- REGN quarterly accounts payable is now -10.64% below its all-time high of $789.50 million, reached on December 31, 2024.
Performance
REGN quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
REGN Accounts payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +30.1% | +5.1% |
3 y3 years | +40.0% | +50.0% |
5 y5 years | +88.8% | +102.8% |
REGN Accounts payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +40.0% | -10.6% | +50.0% |
5 y | 5-year | at high | +88.8% | -10.6% | +102.8% |
alltime | all time | at high | >+9999.0% | -10.6% | >+9999.0% |
REGN Accounts payable History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $705.50M(-10.6%) |
Dec 2024 | $789.50M(+30.2%) | $789.50M(+58.8%) |
Sep 2024 | - | $497.30M(-11.5%) |
Jun 2024 | - | $561.70M(-16.3%) |
Mar 2024 | - | $671.30M(+10.7%) |
Dec 2023 | $606.60M(+3.0%) | $606.60M(+13.0%) |
Sep 2023 | - | $536.60M(-2.0%) |
Jun 2023 | - | $547.30M(-8.7%) |
Mar 2023 | - | $599.50M(+1.7%) |
Dec 2022 | $589.20M(+4.5%) | $589.20M(+10.0%) |
Sep 2022 | - | $535.60M(+0.3%) |
Jun 2022 | - | $534.20M(+13.6%) |
Mar 2022 | - | $470.30M(-16.6%) |
Dec 2021 | $564.00M(+18.6%) | $564.00M(+32.1%) |
Sep 2021 | - | $427.00M(-10.3%) |
Jun 2021 | - | $476.00M(-12.3%) |
Mar 2021 | - | $542.90M(+14.2%) |
Dec 2020 | $475.50M(+13.7%) | $475.50M(+7.3%) |
Sep 2020 | - | $443.10M(+16.6%) |
Jun 2020 | - | $380.10M(+9.3%) |
Mar 2020 | - | $347.80M(-16.8%) |
Dec 2019 | $418.10M(+91.6%) | $418.10M(+24.6%) |
Sep 2019 | - | $335.60M(+37.5%) |
Jun 2019 | - | $244.00M(+1.8%) |
Mar 2019 | - | $239.60M(+9.8%) |
Dec 2018 | $218.20M(+22.4%) | $218.20M(+26.6%) |
Sep 2018 | - | $172.36M(+0.3%) |
Jun 2018 | - | $171.91M(-17.2%) |
Mar 2018 | - | $207.61M(+16.5%) |
Dec 2017 | $178.20M(+32.0%) | $178.20M(+15.8%) |
Sep 2017 | - | $153.95M(+1.7%) |
Jun 2017 | - | $151.37M(+6.7%) |
Mar 2017 | - | $141.80M(+5.1%) |
Dec 2016 | $134.98M(-4.2%) | $134.98M(+8.4%) |
Sep 2016 | - | $124.50M(+22.4%) |
Jun 2016 | - | $101.72M(-15.7%) |
Mar 2016 | - | $120.59M(-14.4%) |
Dec 2015 | $140.96M(+41.7%) | $140.96M(+31.8%) |
Sep 2015 | - | $106.92M(-17.8%) |
Jun 2015 | - | $130.02M(+43.5%) |
Mar 2015 | - | $90.60M(-9.0%) |
Dec 2014 | $99.51M(+60.7%) | $99.51M(+110.2%) |
Sep 2014 | - | $47.34M(+0.2%) |
Jun 2014 | - | $47.23M(+44.5%) |
Mar 2014 | - | $32.69M(-47.2%) |
Dec 2013 | $61.94M(+59.1%) | $61.94M(+98.6%) |
Sep 2013 | - | $31.19M(+27.8%) |
Jun 2013 | - | $24.42M(-1.3%) |
Mar 2013 | - | $24.73M(-36.5%) |
Dec 2012 | $38.93M(+40.4%) | $38.93M(+77.4%) |
Sep 2012 | - | $21.94M(-14.5%) |
Jun 2012 | - | $25.67M(+1.1%) |
Mar 2012 | - | $25.39M(-8.5%) |
Dec 2011 | $27.74M(+77.9%) | $27.74M(+60.2%) |
Sep 2011 | - | $17.31M(-33.3%) |
Jun 2011 | - | $25.95M(+60.8%) |
Mar 2011 | - | $16.15M(+3.6%) |
Dec 2010 | $15.59M(+148.7%) | $15.59M(+19.6%) |
Jun 2009 | - | $13.03M(-26.7%) |
Mar 2009 | - | $17.78M(+183.6%) |
Dec 2008 | $6.27M(-22.9%) | $6.27M(-52.5%) |
Sep 2008 | - | $13.19M(+26.4%) |
Jun 2008 | - | $10.44M(+10.1%) |
Mar 2008 | - | $9.47M(+16.6%) |
Dec 2007 | $8.13M | $8.13M(+52.5%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2007 | - | $5.33M(-71.3%) |
Jun 2007 | - | $18.55M(+286.0%) |
Mar 2007 | - | $4.80M(-77.6%) |
Dec 2006 | $21.47M(+410.8%) | $21.47M(+487.1%) |
Sep 2006 | - | $3.66M(+28.8%) |
Jun 2006 | - | $2.84M(-24.4%) |
Mar 2006 | - | $3.76M(-10.6%) |
Dec 2005 | $4.20M(-77.7%) | $4.20M(-79.6%) |
Sep 2005 | - | $20.60M(+20.9%) |
Jun 2005 | - | $17.04M(-2.4%) |
Mar 2005 | - | $17.47M(-7.4%) |
Dec 2004 | $18.87M(-0.3%) | $18.87M(-7.0%) |
Sep 2004 | - | $20.28M(+28.8%) |
Jun 2004 | - | $15.74M(-16.9%) |
Mar 2004 | - | $18.95M(+0.1%) |
Dec 2003 | $18.93M(-37.5%) | $18.93M(-9.7%) |
Sep 2003 | - | $20.97M(+49.3%) |
Jun 2003 | - | $14.04M(-44.3%) |
Mar 2003 | - | $25.20M(-16.9%) |
Dec 2002 | $30.31M(+104.4%) | $30.31M(+24.3%) |
Sep 2002 | - | $24.38M(+44.0%) |
Jun 2002 | - | $16.93M(-0.8%) |
Mar 2002 | - | $17.07M(+15.1%) |
Dec 2001 | $14.83M(+57.0%) | $14.83M(+46.5%) |
Sep 2001 | - | $10.12M(+21.9%) |
Jun 2001 | - | $8.30M(-11.7%) |
Mar 2001 | - | $9.40M(-0.4%) |
Dec 2000 | $9.45M(+43.1%) | $9.45M(+17.8%) |
Sep 2000 | - | $8.02M(+5.0%) |
Jun 2000 | - | $7.64M(+10.3%) |
Mar 2000 | - | $6.92M(+4.9%) |
Dec 1999 | $6.60M(+17.9%) | $6.60M(+46.7%) |
Sep 1999 | - | $4.50M(-8.2%) |
Jun 1999 | - | $4.90M(-18.3%) |
Mar 1999 | - | $6.00M(+7.1%) |
Dec 1998 | $5.60M(+19.1%) | $5.60M(+27.3%) |
Sep 1998 | - | $4.40M(-13.7%) |
Jun 1998 | - | $5.10M(+37.8%) |
Mar 1998 | - | $3.70M(-21.3%) |
Dec 1997 | $4.70M(+6.8%) | $4.70M(+14.6%) |
Sep 1997 | - | $4.10M(-19.6%) |
Jun 1997 | - | $5.10M(+50.0%) |
Mar 1997 | - | $3.40M(-22.7%) |
Dec 1996 | $4.40M(-30.2%) | $4.40M(+4.8%) |
Sep 1996 | - | $4.20M(0.0%) |
Jun 1996 | - | $4.20M(-2.3%) |
Mar 1996 | - | $4.30M(-31.7%) |
Dec 1995 | $6.30M(+26.0%) | $6.30M(+46.5%) |
Sep 1995 | - | $4.30M(-6.5%) |
Jun 1995 | - | $4.60M(+24.3%) |
Mar 1995 | - | $3.70M(-26.0%) |
Dec 1994 | $5.00M(-51.5%) | $5.00M(+19.0%) |
Sep 1994 | - | $4.20M(-34.4%) |
Jun 1994 | - | $6.40M(+6.7%) |
Mar 1994 | - | $6.00M(-41.7%) |
Dec 1993 | $10.30M(+312.0%) | $10.30M(+53.7%) |
Sep 1993 | - | $6.70M(+28.8%) |
Jun 1993 | - | $5.20M(+73.3%) |
Mar 1993 | - | $3.00M(+20.0%) |
Dec 1992 | $2.50M(+56.3%) | $2.50M(+31.6%) |
Jun 1992 | - | $1.90M(0.0%) |
Mar 1992 | - | $1.90M(+18.8%) |
Dec 1991 | $1.60M | $1.60M(+220.0%) |
Sep 1991 | - | $500.00K(-37.5%) |
Jun 1991 | - | $800.00K |
FAQ
- What is Regeneron Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual accounts payable year-on-year change?
- What is Regeneron Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly accounts payable year-on-year change?
What is Regeneron Pharmaceuticals annual accounts payable?
The current annual accounts payable of REGN is $789.50M
What is the all time high annual accounts payable for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual accounts payable is $789.50M
What is Regeneron Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, REGN annual accounts payable has changed by +$182.90M (+30.15%)
What is Regeneron Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of REGN is $705.50M
What is the all time high quarterly accounts payable for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly accounts payable is $789.50M
What is Regeneron Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, REGN quarterly accounts payable has changed by +$34.20M (+5.09%)